← Back to Clinical Trials
Recruiting NCT06156813

NCT06156813 Turkish Lower-Extremity Motor Activity Log (LE-MAL)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06156813
Status Recruiting
Phase
Sponsor Gaziantep Islam Science and Technology University
Condition Stroke
Study Type OBSERVATIONAL
Enrollment 80 participants
Start Date 2023-11-15
Primary Completion 2025-12-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type OBSERVATIONAL
Interventions
Diagnostic test

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 80 participants in total. It began in 2023-11-15 with a primary completion date of 2025-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The Motor Activity Log was developed to measure paretic upper extremity use in daily activities in the real-life context (real world) of people with different health conditions, including stroke. Subsequently, the Lower Extremity Motor Activity Diary was developed. This survey is a semi-structured survey in which the participant is asked to rate himself/herself according to each scale over 14 activities.

Eligibility Criteria

Inclusion Criteria: * Individuals between the ages of 18-80 living in Gaziantep who applied to the neurology outpatient clinic of Hospital and were diagnosed with stroke. Exclusion Criteria: * Patients with a history of trauma within the last year, alcohol and substance addiction, and pregnancy

Contact & Investigator

Central Contact

Zekiye İpek Katırcı Kırmacı, PhD

✉ ipekkatirci@hotmail.com

📞 +90 544 261 82 85

Principal Investigator

Zekiye İpek Katırcı Kırmacı

PRINCIPAL INVESTIGATOR

Gaziantep Islam Science and Technology University

Frequently Asked Questions

Who can join the NCT06156813 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06156813 currently recruiting?

Yes, NCT06156813 is actively recruiting participants. Contact the research team at ipekkatirci@hotmail.com for enrollment information.

Where is the NCT06156813 trial being conducted?

This trial is being conducted at Gaziantep, Turkey (Türkiye).

Who is sponsoring the NCT06156813 clinical trial?

NCT06156813 is sponsored by Gaziantep Islam Science and Technology University. The principal investigator is Zekiye İpek Katırcı Kırmacı at Gaziantep Islam Science and Technology University. The trial plans to enroll 80 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology